patch

Nutriband Inc. Announces the Appointment of Larry Dillaha, MD as Chief Medical Officer and to Advisory Board

News / By

ORLANDO, Fla., Aug. 2, 2018 /PRNewswire/ — Nutriband Inc. (OTCQB: NTRB) announced the appointment of Larry Dillaha, MD as chief medical officer and as a member of its Pharmaceutical Advisory Board. Dr. Dillaha brings nearly 20 years of pharmaceutical industry experience to Nutriband. Prior to joining Nutriband, he was chief executive officer of Repros Therapeutics from February 2017 to February 2018. …

Nutriband Inc. Announces the Appointment of Larry Dillaha, MD as Chief Medical Officer and to Advisory Board Read More »

Nutriband Inc. Completes Acquisition of 4P Therapeutics Inc.

News / By

ORLANDO, Fla., Aug. 1, 2018 /PRNewswire/ — Nutriband Inc. (OTCQB: NTRB) announced the formal completion of the acquisition of Atlanta-based 4P Therapeutics Inc. Pursuant to the previously announced acquisition agreement, on Aug 1, 2018, Nutriband completed the acquisition of 4P Therapeutics for 250,000 shares of Nutriband’s common stock and cash of $400,000. Gareth Sheridan, Chief Executive Officer of Nutriband, said, …

Nutriband Inc. Completes Acquisition of 4P Therapeutics Inc. Read More »

Nutriband Inc. Announces the Appointment of Dr. Jeff Patrick as Chief Scientific Officer and to Head of Advisory Board

News / By

ORLANDO, Fla., May 15, 2018  — Nutriband Inc. (OTC: NTRB), a Nevada Corporation, is pleased to announce that it has appointed Jeff Patrick PharmD as Chief Scientific Officer and to head of its Pharmaceutical Advisory Board. Dr. Jeff Patrick Jeff Patrick Pharm.D. currently serves as Director of Drug Development Institute at the Ohio State University Comprehensive Cancer Center. Dr. Patrick …

Nutriband Inc. Announces the Appointment of Dr. Jeff Patrick as Chief Scientific Officer and to Head of Advisory Board Read More »

Nutriband - Leaders in Transdermal Technology

Nutriband Inc. Acquires 4P Therapeutics Inc.

News / By

ORLANDO, Fla., April 10, 2018 /PRNewswire/ — Nutriband Inc. (OTC: NTRB), a Nevada Corporation, is pleased to announce the acquisition of 4P Therapeutics Inc. on April 5, 2018.   Nutriband has acquired 100% interest in 4P Therapeutics for a total of $1,900,000 payable in both company stock and cash.  4P Therapeutics will receive 250,000 shares of common stock and a …

Nutriband Inc. Acquires 4P Therapeutics Inc. Read More »